Tango Therapeutics Inc
NASDAQ:TNGX

Watchlist Manager
Tango Therapeutics Inc Logo
Tango Therapeutics Inc
NASDAQ:TNGX
Watchlist
Price: 3.15 USD 1.61%
Market Cap: 338.4m USD
Have any thoughts about
Tango Therapeutics Inc?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

352.4m
-8%
Assets
Growth Rates:
1 Year
-18%
3 Years
-34%
5 Years
-
7 Years
-
10 Years
-
123.2m
-8%
Liabilities
Growth Rates:
1 Year
-19%
3 Years
-25%
5 Years
-
7 Years
-
10 Years
-
229.2m
-7%
Equity
Growth Rates:
1 Year
-17%
3 Years
-37%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Tango Therapeutics Inc

352.4m
Assets
123.2m
Liabilities
352.4m
Assets
123.2m
Liabilities
Current Assets 300.8m
Cash & Short-Term Investments 293.3m
Other Current Assets 7.5m
Non-Current Assets 51.6m
PP&E 49m
Other Non-Current Assets 2.6m
Current Liabilities 37.6m
Accounts Payable 4.1m
Accrued Liabilities 17.9m
Other Current Liabilities 15.6m
Non-Current Liabilities 85.7m
Other Non-Current Liabilities 85.7m

Balance Sheet
Tango Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1
143
60
66
Cash
1
0
0
0
Cash Equivalents
0
143
60
66
Short-Term Investments
0
343
306
271
Total Receivables
0
2
2
0
Accounts Receivables
0
2
2
0
Other Receivables
0
0
0
0
Other Current Assets
0
5
7
10
Total Current Assets
2
492
375
347
PP&E Net
0
6
58
53
PP&E Gross
0
6
58
53
Accumulated Depreciation
0
3
4
6
Long-Term Investments
167
0
0
0
Other Long-Term Assets
0
2
3
3
Total Assets
168
N/A
500
+197%
437
-13%
403
-8%
Liabilities
Accounts Payable
0
3
5
3
Accrued Liabilities
0
11
19
17
Short-Term Debt
0
0
0
0
Other Current Liabilities
0
26
32
26
Total Current Liabilities
0
41
56
46
Long-Term Debt
0
0
0
0
Other Liabilities
6
115
131
104
Total Liabilities
6
N/A
155
+2 490%
187
+20%
149
-20%
Equity
Common Stock
157
0
0
0
Retained Earnings
0
161
270
371
Additional Paid In Capital
5
507
523
624
Other Equity
0
1
4
0
Total Equity
162
N/A
345
+112%
250
-28%
253
+1%
Total Liabilities & Equity
168
N/A
500
+197%
437
-13%
403
-8%
Shares Outstanding
Common Shares Outstanding
21
88
88
102

See Also

Summary
TNGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
TNGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TNGX stock valuation using valuation multiples.
Wall Street Estimates
TNGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TNGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.